[1] Cowie MR, Mendez GF. BNP and congestive heart failure[J]. Prog Cardiovas Dis, 2002, 44(4): 293-321. [2] Sudoh T, Kangawa K, Minamino N, et al. A new natriuretic peptide in porcine brain[J]. Nature, 1988, 332(6159): 78-81. [3] Wilkins MR, Redondo J, Brown LA. The natriuretic peptide family[J]. Lancet, 1997, 349(9061): 1307-10. [4] Takahashi M, Nagake Y, Ichikawa H, et al. Plasma concentrations of natriuretic peptides in patients on hemodialysis [J]. Res Commun Mol Pathol Pharmacol, 1996, 92(1): 19-30. [5] Cataliotti A, Malatino LS, Jougasaki M, et al. Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling[J]. Mayo Clin Proc, 2001, 76(11): 1111-9. [6] Buckley MG, Sethi D, Markandu ND, et al. Plasma concentrations and comparisons of brain natriuretic peptide and atrial natriuretic peptide in normal subjects, cardiac transplant recipients and patients with dialysis-independent or dialysis-dependent chronic renal failure[J]. Clin Sci (Lond), 1992, 83(4): 437-44. [7] Nitta K, Kawashima A, Yumura W, et al. Plasma concentration of brain natriuretic peptide as an indicator of cardiac ventricular function in patients on hemodialysis[J]. Am J Nephrol, 1998, 18(5):411-5. [8] Selvais PL, Donckier JE, Robert A, et al. Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure: influences of left ventricular dysfunction and coronary artery disease on cardiac hormonal activation[J]. Eur J Clin Invest, 1998, 28(8): 636-42. [9] Naganuma T, Sugimura K, Wada S, et al. The prognostic role of brain natriuretic peptides in hemodialysis patients [J]. Am J Nephrol, 2002, 22(5-6): 437-44. [10] Takami Y, Horio T, Iwashima Y, et al. Diagnostic and prognostic value of plasma brain natriuretic peptide in non-dialysis-dependent CRF[J]. Am J Kidney Dis, 2004, 44(3): 420-8. |